EP0598759A4 - Recombinant infectious bovine rhinotracheitis virus. - Google Patents

Recombinant infectious bovine rhinotracheitis virus.

Info

Publication number
EP0598759A4
EP0598759A4 EP92916108A EP92916108A EP0598759A4 EP 0598759 A4 EP0598759 A4 EP 0598759A4 EP 92916108 A EP92916108 A EP 92916108A EP 92916108 A EP92916108 A EP 92916108A EP 0598759 A4 EP0598759 A4 EP 0598759A4
Authority
EP
European Patent Office
Prior art keywords
rhinotracheitis virus
infectious bovine
bovine rhinotracheitis
recombinant infectious
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92916108A
Other languages
German (de)
French (fr)
Other versions
EP0598759A1 (en
Inventor
Mark D Cochran
Richard D Macdonald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntro Corp
Original Assignee
Syntro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntro Corp filed Critical Syntro Corp
Publication of EP0598759A1 publication Critical patent/EP0598759A1/en
Publication of EP0598759A4 publication Critical patent/EP0598759A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
EP92916108A 1991-07-18 1992-07-20 Recombinant infectious bovine rhinotracheitis virus. Withdrawn EP0598759A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73258491A 1991-07-18 1991-07-18
US732584 1991-07-18
PCT/US1992/006034 WO1993002104A1 (en) 1991-07-18 1992-07-20 Recombinant infectious bovine rhinotracheitis virus

Publications (2)

Publication Number Publication Date
EP0598759A1 EP0598759A1 (en) 1994-06-01
EP0598759A4 true EP0598759A4 (en) 1998-06-03

Family

ID=24944128

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92916108A Withdrawn EP0598759A4 (en) 1991-07-18 1992-07-20 Recombinant infectious bovine rhinotracheitis virus.

Country Status (4)

Country Link
EP (1) EP0598759A4 (en)
AU (1) AU672583B2 (en)
CA (1) CA2113641A1 (en)
WO (1) WO1993002104A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783195A (en) * 1991-07-18 1998-07-21 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus S-IBR-052 and uses thereof
US6410033B1 (en) 1987-07-27 2002-06-25 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
FR2693472B1 (en) * 1992-06-26 1994-12-23 Rhone Merieux Mutants of the infectious bovine rhinotracheitis virus, deleted in one of the genes of minor glycoproteins, vaccines prepared from these strains, production methods and methods of use.
WO1994024296A2 (en) * 1993-04-19 1994-10-27 University Of Saskatchewan Recombinant bovine herpesvirus type 1 vaccines
CA2136381A1 (en) * 1993-11-23 1995-05-24 Gunther Keil Vector vaccines of bovine herpesvirus 1
EP0663403A1 (en) * 1993-11-23 1995-07-19 Akzo Nobel N.V. Vector vaccines of bovine herpesvirus I
ES2074965B1 (en) * 1994-01-31 1996-05-01 Hipra Lab Sa RECOMBINANT MUTANT VIRUSES OF INFECTIOUS BOVINE RHINOTRACHEITIS AND VACCINES THAT CONTAIN IT.
US6284251B1 (en) 1996-02-26 2001-09-04 Kansas State University Research Foundation BHV-1 gene-deleted virus vaccine

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987004463A1 (en) * 1986-01-27 1987-07-30 Syntro Corporation Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
WO1989001040A1 (en) * 1987-07-27 1989-02-09 Syntro Corporation Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same
EP0316658A1 (en) * 1987-11-03 1989-05-24 Novagene, Inc. Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
EP0326127A2 (en) * 1988-01-26 1989-08-02 Novagene, Inc. Infectious bovine rhinotracheitis virus insertion mutants, vaccins containing same, and methods for the production and use of same
EP0471457A2 (en) * 1990-07-24 1992-02-19 Novagene, Inc. Herpesvirus-based viral vector which expresses a foot & mouth disease virus epitope
WO1992021751A1 (en) * 1991-06-07 1992-12-10 Stichting Centraal Diergeneeskundig Instituut Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132775A (en) * 1973-12-03 1979-01-02 Richardson-Merrell Inc. Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same
CA1339735C (en) * 1984-04-27 1998-03-17 Ian Hamilton Holmes. Cloning and sequencing of the major outer capsid gylcoprotein gene of a human rotavirus
AU591145B2 (en) * 1985-07-29 1989-11-30 Pharmacia & Upjohn Company Virus vaccine with deletion of an antigen of the wild-type virus
US4877737A (en) * 1985-09-06 1989-10-31 Prutech Research And Development Partnership Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same
US4703011A (en) * 1985-11-12 1987-10-27 Novagene, Inc. Thymidine kinase deletion mutants of bovine herpesvirus-1

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987004463A1 (en) * 1986-01-27 1987-07-30 Syntro Corporation Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
WO1989001040A1 (en) * 1987-07-27 1989-02-09 Syntro Corporation Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same
EP0316658A1 (en) * 1987-11-03 1989-05-24 Novagene, Inc. Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
EP0326127A2 (en) * 1988-01-26 1989-08-02 Novagene, Inc. Infectious bovine rhinotracheitis virus insertion mutants, vaccins containing same, and methods for the production and use of same
EP0471457A2 (en) * 1990-07-24 1992-02-19 Novagene, Inc. Herpesvirus-based viral vector which expresses a foot & mouth disease virus epitope
WO1992021751A1 (en) * 1991-06-07 1992-12-10 Stichting Centraal Diergeneeskundig Instituut Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
KIT S ET AL: "Exprssion of pseudorabies virus and foot-and -mouth disease virus proteins by modified-live infectious bovine rhinotracheitis virus vectors", PROCEEDING OF THE 94TH ANNUAL MEETING OF THE UNITED STATES ANIMAL HEALTH ASSOCIATION, 1990, US, pages 66 - 75, XP002060268 *
LONGNECKER R ET AL: "Clustering of genes dispensable for growth in culture in the S component of the HSV-1 genome", SCIENCE, vol. 236, 1987, LANCASTER, PA US, pages 573 - 576, XP002034507 *
MCGEOCH D: "Evolutionary relationships of virion glycoprotein genes in the S regions of alphaherpesvirus genomes", JOURNAL OF GENERAL VIROLOGY, vol. 71, 1990, READING GB, pages 2361 - 2367, XP002034509 *
See also references of WO9302104A1 *
WEBER PC ET AL: "Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis", SCIENCE, vol. 236, 1987, LANCASTER, PA US, pages 576 - 579, XP002034508 *

Also Published As

Publication number Publication date
AU672583B2 (en) 1996-10-10
CA2113641A1 (en) 1993-02-04
AU2393292A (en) 1993-02-23
WO1993002104A1 (en) 1993-02-04
EP0598759A1 (en) 1994-06-01

Similar Documents

Publication Publication Date Title
GB2245272B (en) Recombinant virus selection system
GB9115909D0 (en) Recombinant dna
AU2371692A (en) Recombinant hepatitis a virus vaccine
GB9303023D0 (en) Flavivirus recombinant poxvirus vaccine
EP0708658A4 (en) Recombinant cytomegalovirus vaccine
HU912526D0 (en) Recombinant marek-type disease virus
ZA935723B (en) Hepatitis A virus vaccine.
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
GB2264949B (en) Measles virus recombinant poxvirus vaccine
EP0598759A4 (en) Recombinant infectious bovine rhinotracheitis virus.
AU5679394A (en) Hepatitis b virus vaccines
IL101639A0 (en) Recombinant influenza vaccines
EP0710120A4 (en) Recombinant swinepox virus
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
AU2347692A (en) Recombinant viral vaccine
GB8305323D0 (en) Infectious bovine rhinotracheitis vaccine
EP0745133A4 (en) Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof
HU9203976D0 (en) Vaccine based on modified herpes virus
EP0244427A4 (en) Recombinant virus.
EP0537232A4 (en) Recombinant pigeon pox virus vaccine
EP0580758A4 (en) Anti-human immunodeficiency virus recombinant antibodies.
GB9220010D0 (en) Recombinant virus
GB9304962D0 (en) Recombinant virus
GB9315259D0 (en) Recombinant viruses
GB9324964D0 (en) Viral vaccines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940218

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

RHK1 Main classification (correction)

Ipc: C12N 15/38

A4 Supplementary search report drawn up and despatched

Effective date: 19980420

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

17Q First examination report despatched

Effective date: 19981116

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/38 A, 7C 07K 14/03 B, 7C 12N 7/01 B, 7C 12N 15/63 B

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/38 A, 7C 07K 14/03 B, 7C 12N 7/01 B, 7C 12N 15/63 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030403